Literature DB >> 1314054

Reinfection and reactivation of equine herpesvirus-1 in the mouse.

H J Field1, A R Awan, R de la Fuente.   

Abstract

Balb/c mice were inoculated with equine herpesvirus-1 (EHV-1) by the intranasal (i.n.) route. Mice developed respiratory signs; virus replication occurred in the respiratory tract and viraemia was detected; some mice died. Recovered mice were given a second inoculation with the same strain 5 months later. Following the second infection no mice died, however, virus replication was again observed in the respiratory tract and viraemia was detected once more. Administration of an antiviral agent during the acute infection prevented mice from developing severe clinical signs and all survived. These mice, and some that had survived an acute infection without chemotherapy, were given a variety of stimuli, for example X-irradiation or corticosteroid injection. Reappearance of infectious virus was detected in approx. 1/3 animals in either the respiratory tract or blood. We speculate on the possible sites of latency in the model.

Entities:  

Mesh:

Year:  1992        PMID: 1314054     DOI: 10.1007/bf01317274

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  22 in total

1.  Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals.

Authors:  M R Boyd; T H Bacon; D Sutton
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

Review 2.  Latent herpes simplex virus and the nervous system,.

Authors:  J G Stevens
Journal:  Curr Top Microbiol Immunol       Date:  1975       Impact factor: 4.291

3.  A novel selective broad-spectrum anti-DNA virus agent.

Authors:  E De Clercq; A Holý; I Rosenberg; T Sakuma; J Balzarini; P C Maudgal
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

4.  Spread of herpes simplex virus in peripheral nerves.

Authors:  K Kristensson; E Lycke; J Sjöstrand
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

5.  Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans.

Authors:  S Efstathiou; A C Minson; H J Field; J R Anderson; P Wildy
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

6.  Reactivation of latent herpes simplex virus-1 (HSV) from mouse footpad cells demonstrated by in situ hybridization.

Authors:  G B Clements; F E Jamieson
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  Effective chemotherapy of equine herpesvirus 1 by phosphonylmethoxyalkyl derivatives of adenine demonstrated in a novel murine model for the disease.

Authors:  H J Field; A R Awan
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

8.  The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection.

Authors:  A R Awan; Y C Chong; H J Field
Journal:  J Gen Virol       Date:  1990-05       Impact factor: 3.891

9.  Investigation of herpes simplex virus type 1 (HSV-1) gene expression and DNA synthesis during the establishment of latent infection by an HSV-1 mutant, in1814, that does not replicate in mouse trigeminal ganglia.

Authors:  T Valyi-Nagy; S L Deshmane; J G Spivack; I Steiner; C I Ace; C M Preston; N W Fraser
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

10.  A murine model for studying EHV-1-induced abortion.

Authors:  A R Awan; J S Gibson; H J Field
Journal:  Res Vet Sci       Date:  1991-07       Impact factor: 2.534

View more
  3 in total

1.  CCL3 and viral chemokine-binding protein gg modulate pulmonary inflammation and virus replication during equine herpesvirus 1 infection.

Authors:  Gerlinde R Van de Walle; Kaori Sakamoto; Nikolaus Osterrieder
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

2.  In situ study on the pathogenesis and immune reaction of equine herpesvirus type 1 (EHV-1) infections in mice.

Authors:  T Bartels; F Steinbach; G Hahn; H Ludwig; K Borchers
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

3.  The equine herpesvirus 1 (EHV-1) UL3 gene, an ICP27 homolog, is necessary for full activation of gene expression directed by an EHV-1 late promoter.

Authors:  R H Smith; Y Zhao; D J O'Callaghan
Journal:  J Virol       Date:  1993-02       Impact factor: 6.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.